Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Tinea Imbricata: An Overview

Author(s): Alexander K.C. Leung*, Kin F. Leong and Joseph M. Lam

Volume 15, Issue 3, 2019

Page: [170 - 174] Pages: 5

DOI: 10.2174/1573396315666190207151941

Abstract

Background: Tinea imbricata is a chronic superficial mycosis caused mainly by Trichophyton concentricum. The condition mainly affects individuals living in primitive and isolated environment in developing countries and is rarely seen in developed countries. Physicians in nonendemic areas might not be aware of this fungal infection.

Objective: To familiarize physicians with the clinical manifestations, diagnosis, and treatment of tinea imbricata.

Methods: A PubMed search was completed in Clinical Queries using the key terms "Tinea imbricata" and "Trichophyton concentricum". The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies, reviews, and case reports. The information retrieved from the above search was used in the compilation of the present article.

Results: The typical initial lesions of tinea imbricata consist of multiple, brownish red, scaly, pruritic papules. The papules then spread centrifugally to form annular and/or concentric rings that can extend to form serpinginous or polycyclic plaques with or without erythema. With time, multiple overlapping lesions develop, and the plaques become lamellar with abundant thick scales adhering to the interior of the lesion, giving rise to the appearance of overlapping roof tiles, lace, or fish scales. Lamellar detachment of the scales is common. The diagnosis is mainly clinical, based on the characteristic skin lesions. If necessary, the diagnosis can be confirmed by potassium hydroxide wet-mount examination of skin scrapings of the active border of the lesion which typically shows short septate hyphae, numerous chlamydoconidia, and no arthroconidia. Currently, oral terbinafine is the drug of choice for the treatment of tinea imbricata. Combined therapy of an oral antifungal agent with a topical antifungal and keratolytic agent may increase the cure rate.

Conclusion: In most cases, a spot diagnosis of tinea imbricata can be made based on the characteristic skin lesions consisting of scaly, concentric annular rings and overlapping plaques that are pruritic. Due to popularity of international travel, physicians involved in patient care should be aware of this fungal infection previously restricted to limited geographical areas.

Keywords: Trichphyton concentricum, pruritic, concentric, annular, rings, lamellar, plaques, scales, oral terbinafine.

« Previous Next »
Graphical Abstract

[1]
Esposto MC, Lazzarini C, Prigitano A, Olivi A, Monti M, Tortorano AM. Trichophyton concentricum in skin lesions in children from the Salomon Islands. G Ital Dermatol Venereol 2015; 150(5): 491-4.
[PMID: 26333549]
[2]
Leung AKC, Leong KF, Lam JM. Tinea Imbricata. J Pediatr 2018; 200: 285-285.e1.
[http://dx.doi.org/10.1016/j.jpeds.2018.04.012] [PMID: 29747932]
[3]
Pihet M, Bourgeois H, Mazière JY, Berlioz-Arthaud A, Bouchara JP, Chabasse D. Isolation of Trichophyton concentricum from chronic cutaneous lesions in patients from the Solomon Islands. Trans R Soc Trop Med Hyg 2008; 102(4): 389-93.
[http://dx.doi.org/10.1016/j.trstmh.2008.01.002] [PMID: 18295290]
[4]
Veraldi S, Giorgi R, Pontini P, Tadini G, Nazzaro G. Tinea Imbricata in an Italian child and review of the literature. Mycopathologia 2015; 180(5-6): 353-7.
[http://dx.doi.org/10.1007/s11046-015-9930-1] [PMID: 26314408]
[5]
Wingfield AB, Fernandez-Obregon AC, Wignall FS, Greer DL. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. Br J Dermatol 2004; 150(1): 119-26.
[http://dx.doi.org/10.1111/j.1365-2133.2004.05643.x] [PMID: 14746625]
[6]
Manson P. Notes on tinea imbricata, an underdescribed species of body ringworm. Med Rep (China) 1878; 16: 1-11.
[7]
Bonifaz A, Vázquez-González D. Tinea imbricata in the Americas. Curr Opin Infect Dis 2011; 24(2): 106-11.
[http://dx.doi.org/10.1097/QCO.0b013e328342cbc1] [PMID: 21169831]
[8]
Bonifaz A, Araiza J, Koffman-Alfaro S, Paredes-Solis V, Cuevas-Covarrubias S, Rivera MR. Tinea imbricata: autosomal dominant pattern of susceptibility in a polygamous indigenous family of the Nahuatl zone in Mexico. Mycoses 2004; 47(7): 288-91.
[http://dx.doi.org/10.1111/j.1439-0507.2004.00989.x] [PMID: 15310331]
[9]
Bonifaz A, Archer-Dubon C, Saúl A. Tinea imbricata or Tokelau. Int J Dermatol 2004; 43(7): 506-10.
[http://dx.doi.org/10.1111/j.1365-4632.2004.02171.x] [PMID: 15230889]
[10]
Maroñas Jiménez L, Monsálvez V, Gutiérrez García-Rodrigo C, Postigo Llorente C. Tinea imbricata as a clue to occult immunodeficiency. Pediatr Dermatol 2014; 31(6): e126-7.
[http://dx.doi.org/10.1111/pde.12386] [PMID: 25243976]
[11]
Jazwinska EC, Bhatia K, Jenkins C, Serjeantson SW. HLA class II RFLP-typing in tinea imbricata patients from Papua New Guinea. Tissue Antigens 1990; 35(2): 99-100.
[http://dx.doi.org/10.1111/j.1399-0039.1990.tb01763.x] [PMID: 1971464]
[12]
Ravine D, Turner KJ, Alpers MP. Genetic inheritance of susceptibility to tinea imbricata. J Med Genet 1980; 17(5): 342-8.
[http://dx.doi.org/10.1136/jmg.17.5.342] [PMID: 7218274]
[13]
Logan RA, Kobza-Black A. Tinea imbricata in a British nurse. Clin Exp Dermatol 1988; 13(4): 232-3.
[http://dx.doi.org/10.1111/j.1365-2230.1988.tb00685.x] [PMID: 3246087]
[14]
Sonthalia S, Singal A, Das S. Tinea cruris and tinea corporis masquerading as tinea indecisiva: case report and review of the literature. J Cutan Med Surg 2015; 19(2): 171-6.
[http://dx.doi.org/10.2310/7750.2014.14057] [PMID: 25775632]
[15]
Burns C, Valentine J. Tinea Imbricata. N Engl J Med 2016; 375(23): 2272.
[http://dx.doi.org/10.1056/NEJMicm1516757] [PMID: 27959674]
[16]
Veraldi S, Pontini P, Nazzaro G. A case of tinea imbricata in an Italian woman. Acta Derm Venereol 2015; 95(2): 235-7.
[http://dx.doi.org/10.2340/00015555-1887] [PMID: 24806878]
[17]
Hay RJ, Reid S, Talwat E, Macnamara K. Endemic tinea imbricata--a study on Goodenough Island, Papua New Guinea. Trans R Soc Trop Med Hyg 1984; 78(2): 246-51.
[http://dx.doi.org/10.1016/0035-9203(84)90288-8] [PMID: 6464115]
[18]
Satter EK. Tinea imbricata. Cutis 2009; 83(4): 188-91.
[PMID: 19445309]
[19]
Piccolo V, Corneli P, Russo T, Zalaudek I, Alfano R, Argenziano G. Dermoscopy as a useful tool in diagnosis of tinea incognito. Int J Dermatol 2019; 58(2): e32-4.
[http://dx.doi.org/10.1111/ijd.14278] [PMID: 30390303]
[20]
Cinotti E, Perrot JL, Labeille B, Cambazard F. Reflectance confocal microscopy for cutaneous infections and infes0tations. J Eur Acad Dermatol Venereol 2016; 30(5): 754-63.
[http://dx.doi.org/10.1111/jdv.13254] [PMID: 26387660]
[21]
Leung AK, Adams SP, Barankin B. Boy with pruritic rash on both cheeks: Tinea incognito. Consultant for Pediatricians 2013; 12: 20-3.
[22]
Leung AK, Barankin B. An annular lesion on the elbow. Am Fam Physician 2016; 93(5): 397-8.
[PMID: 26926977]
[23]
Batta K, Ramlogan D, Smith AG, Garrido MC, Moss C. ‘Tinea indecisiva’ may mimic the concentric rings of tinea imbricata. Br J Dermatol 2002; 147(2): 384.
[http://dx.doi.org/10.1046/j.1365-2133.2002.04767.x] [PMID: 12174120]
[24]
Hoque SR, Holden CA. Trichophyton tonsurans infection mimicking tinea imbricata. Clin Exp Dermatol 2007; 32(3): 345-6.
[http://dx.doi.org/10.1111/j.1365-2230.2006.02337.x] [PMID: 17397364]
[25]
Lim SP, Smith AG. “Tinea pseudoimbricata”: tinea corporis in a renal transplant recipient mimicking the concentric rings of tinea imbricata. Clin Exp Dermatol 2003; 28(3): 332-3.
[http://dx.doi.org/10.1046/j.1365-2230.2003.01281.x] [PMID: 12780732]
[26]
Ouchi T, Nagao K, Hata Y, Otuka T, Inazumi T. Trichophyton tonsurans infection manifesting as multiple concentric annular erythemas. J Dermatol 2005; 32(7): 565-8.
[http://dx.doi.org/10.1111/j.1346-8138.2005.tb00799.x] [PMID: 16335872]
[27]
Rao AG, Datta N. Tinea corporis due to Trichophyton mentagrophytes and Trichophyton tonsurans mimicking tinea imbricata. Indian J Dermatol Venereol Leprol 2013; 79(4): 554.
[http://dx.doi.org/10.4103/0378-6323.113109] [PMID: 23760341]
[28]
Renati S, Cukras A, Bigby M. Pityriasis versicolor. BMJ 2015; 350: h1394.
[http://dx.doi.org/10.1136/bmj.h1394] [PMID: 25852089]
[29]
Zawar V, Chuh A. Pityriasis versicolor imbricata--overlapping parallel scales in a novel variant of pityriasis versicolor. J Eur Acad Dermatol Venereol 2008; 22(9): 1143-5.
[http://dx.doi.org/10.1111/j.1468-3083.2007.02561.x] [PMID: 18221335]
[30]
Leung AKC, Leong KF, Lam JM. Erythema nodosum. World J Pediatr 2018; 14(6): 548-54.
[http://dx.doi.org/10.1007/s12519-018-0191-1] [PMID: 30269303]
[31]
Liu KL, Tsai WC, Lee CH. Cutaneous sarcoidosis: A retrospective case series and a hospital-based case-control study in Taiwan. Medicine (Baltimore) 2017; 96(40)e8158
[http://dx.doi.org/10.1097/MD.0000000000008158] [PMID: 28984765]
[32]
Reddy R, Vitiello M, Kerdel F. Cutaneous sarcoid mimicking tinea imbricata. Int J Dermatol 2011; 50(9): 1132-4.
[http://dx.doi.org/10.1111/j.1365-4632.2010.04680.x] [PMID: 22126879]
[33]
Balagula Y, Mattei PL, Wisco OJ, Erdag G, Chien AL. The great imitator revisited: the spectrum of atypical cutaneous manifestations of secondary syphilis. Int J Dermatol 2014; 53(12): 1434-41.
[http://dx.doi.org/10.1111/ijd.12518] [PMID: 25312512]
[34]
Cotterman C, Eckert L, Ackerman L. Syphilis mimicking tinea imbricata and erythema annulare centrifugum in an immunocompromised patient. J Am Acad Dermatol 2009; 61(1): 165-7.
[http://dx.doi.org/10.1016/j.jaad.2008.10.027] [PMID: 19539866]
[35]
De La Torre-Lugo EM, Sánchez JL. Erythema gyratum repens. J Am Acad Dermatol 2011; 64(5): e89-90.
[http://dx.doi.org/10.1016/j.jaad.2010.10.006] [PMID: 21496697]
[36]
Rongioletti F, Fausti V, Parodi A. Erythema gyratum repens is not an obligate paraneoplastic disease: a systematic review of the literature and personal experience. J Eur Acad Dermatol Venereol 2014; 28(1): 112-5.
[http://dx.doi.org/10.1111/j.1468-3083.2012.04663.x] [PMID: 22830929]
[37]
Kim DH, Lee JH, Lee JY, Park YM. Erythema annulare centrifugum: Analysis of associated diseases and clinical outcomes according to histopathologic classification. Ann Dermatol 2016; 28(2): 257-9.
[http://dx.doi.org/10.5021/ad.2016.28.2.257] [PMID: 27081281]
[38]
McDaniel B, Cook C. Erythema annulare centrifugum StatPearls Internet. Treasure Island, FL: StatPearls Publishing 2019.
[39]
Thareja S, Paghdal K, Lien MH, Fenske NA. Reticular erythematous mucinosis--a review. Int J Dermatol 2012; 51(8): 903-9.
[http://dx.doi.org/10.1111/j.1365-4632.2011.05292.x] [PMID: 22788804]
[40]
Rubegni P, Sbano P, Risulo M, Poggiali S, Fimiani M. A case of reticular erythematous mucinosis treated with topical tacrolimus. Br J Dermatol 2004; 150(1): 173-4.
[http://dx.doi.org/10.1111/j.1365-2133.2004.05718.x] [PMID: 14746650]
[41]
Budimulja U, Kuswadji K, Bramono S, et al. A double‐blind, randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazole. Br J Dermatol 1994; 130(Suppl. 43): 29-31.
[http://dx.doi.org/10.1111/j.1365-2133.1994.tb06091.x] [PMID: 8186139]

Rights & Permissions Print Cite
Article Metrics
28
7
1
1
© 2024 Bentham Science Publishers | Privacy Policy